Open access · CC-BY
via OpenAlex
Mechanisms Underlying Development of Taurine-Deficient Cardiomyopathy
Stephen W. Schaffer, Takashi Ito, Junichi Azuma, Chian Ju Jong, Jay H. Kramer
Hearts · 2020 · ▲ 10 citations
Abstract
Taurine is a ubiquitous β-amino acid that plays an essential role in ensuring normal mitochondrial and myocardial function. In the mitochondria, taurine reacts with a tRNA forming a 5-taurinomethyluridine conjugate that primarily regulates the biosynthesis of the mitochondria encoded protein, ND6, which serves as a subunit of complex I of the respiratory chain. Impaired formation of the taurine conjugate reduces activity of complex I and plays a central role in the pathophysiology of the mitochondrial disease MELAS (myopathy, encephalopathy, lactic acidosis and stroke-like episodes). The restoration of mitochondrial levels of the taurine conjugate enhances electron flux through the respiratory chain, thereby preventing at least some of the symptoms of MELAS. Taurine therapy also diminishes the severity of congestive heart failure, an observation that led to its approval for the treatment of congestive heart failure in Japan. The review article discusses the role of defective calcium handling, reduced ATP generation, enhanced oxidative stress and apoptosis in the development of taurine-deficient cardiomyopathy. Some patients suffering from congestive heart failure are taurine-deficient, an observation supporting the hypothesis that low taurine levels contribute to the severity of heart failure. Thus, mishandling of taurine leads to mitochondrial dysfunction(definition), which is involved in the development of both MELAS and congestive heart failure.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/hearts1020010
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Schaffer, S.W., Ito, T., Azuma, J., Jong, C.J., & Kramer, J.H. (2020). Mechanisms Underlying Development of Taurine-Deficient Cardiomyopathy. <em>Hearts</em>. https://doi.org/10.3390/hearts1020010
Vancouver
Schaffer SW, Ito T, Azuma J, Jong CJ, Kramer JH. Mechanisms Underlying Development of Taurine-Deficient Cardiomyopathy. Hearts. 2020. doi:10.3390/hearts1020010.
BibTeX
@article{stephen2020Mechan,
title = {Mechanisms Underlying Development of Taurine-Deficient Cardiomyopathy},
author = {Stephen W. Schaffer and Takashi Ito and Junichi Azuma and Chian Ju Jong and Jay H. Kramer},
journal = {Hearts},
year = {2020},
doi = {10.3390/hearts1020010},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Basic Research in Cardiology 2012
Open access · CC-BY
Emerging beneficial roles of sirtuins in heart failure
Journal of Clinical Investigation 2005
Preprint · OA
Mitochondrial energy metabolism in heart failure: a question of balance
Circulation Research 2021
Open access · OA
Cardiac Energy Metabolism in Heart Failure
Cell Biochemistry and Biophysics 2024
Preprint · OA
Proteostasis and Its Role in Disease Development
The Research Repository @ WVU (West Virginia University) 2026
Preprint · OA
GCN5L1-mediated lysine acetylation regulates mitochondrial dysfunction in the aged heart
Cell Death and Disease 2024
Open access · CC-BY